New Data-sharing Program Aims to Speed Innovation in Rare Diseases

New Data-sharing Program Aims to Speed Innovation in Rare Diseases

307539

New Data-sharing Program Aims to Speed Innovation in Rare Diseases

A new U.S. initiative called Rare Disease Cures Accelerator–Data and Analytics Platform — dubbed RDCA–DAP — aims to accelerate treatment innovation across rare diseases by sharing existing patient data and promoting the standardization of new data collection. Launched during a virtual workshop in September, the U.S. Food and Drug Administration (FDA)-funded initiative includes rare disease data from clinical trials, observational studies, patient registries, and real-world data. It also provides workspaces with advanced analytics for data…

You must be logged in to read/download the full post.